Income Statement (TTM)
Pharmaron Beijing Co., Ltd. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2023 01-01 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,717 | 5,134 | 5,664 | 6,226 | 6,849 | 7,444 | 8,057 | 8,793 | 9,545 | 10,266 | 10,887 | 11,272 | 11,424 | 11,538 | 11,485 | 11,502 | 11,795 | 12,276 | 12,704 | 13,112 |
| Change (%) | 8.84 | 10.33 | 9.93 | 10.01 | 8.68 | 8.24 | 9.13 | 8.55 | 7.56 | 6.05 | 3.53 | 1.35 | 1.00 | -0.46 | 0.15 | 2.54 | 4.08 | 3.49 | 3.21 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 2,912 | 3,215 | 3,549 | 3,912 | 4,345 | 4,768 | 5,203 | 5,688 | 6,106 | 6,502 | 6,844 | 7,081 | 7,282 | 7,422 | 7,472 | 7,561 | 7,771 | 8,091 | 8,349 | 8,612 |
| Change (%) | 10.39 | 10.38 | 10.24 | 11.08 | 9.72 | 9.13 | 9.33 | 7.35 | 6.47 | 5.26 | 3.47 | 2.84 | 1.92 | 0.67 | 1.19 | 2.77 | 4.13 | 3.18 | 3.16 | |
| % of Revenue | 61.74 | 62.62 | 62.65 | 62.83 | 63.44 | 64.05 | 64.57 | 64.69 | 63.97 | 63.33 | 62.86 | 62.82 | 63.75 | 64.33 | 65.06 | 65.73 | 65.88 | 65.91 | 65.72 | 65.68 |
| Gross Operating Profit | 1,805 | 1,919 | 2,115 | 2,314 | 2,504 | 2,676 | 2,854 | 3,104 | 3,439 | 3,764 | 4,044 | 4,191 | 4,141 | 4,116 | 4,013 | 3,942 | 4,024 | 4,184 | 4,355 | 4,500 |
| Change (%) | 6.34 | 10.23 | 9.41 | 8.20 | 6.87 | 6.66 | 8.76 | 10.76 | 9.48 | 7.42 | 3.63 | -1.18 | -0.61 | -2.50 | -1.78 | 2.10 | 3.97 | 4.08 | 3.33 | |
| % of Revenue | 38.26 | 37.38 | 37.35 | 37.17 | 36.56 | 35.95 | 35.43 | 35.31 | 36.03 | 36.67 | 37.14 | 37.18 | 36.25 | 35.67 | 34.94 | 34.27 | 34.12 | 34.09 | 34.28 | 34.32 |
| SG&A | 691 | 761 | 820 | 856 | 954 | 1,033 | 1,147 | 1,355 | 1,533 | 1,749 | 1,887 | 1,950 | 1,966 | 1,895 | 1,883 | 1,895 | 1,888 | 1,886 | 1,903 | 1,922 |
| Change (%) | 10.08 | 7.75 | 4.46 | 11.43 | 8.24 | 11.08 | 18.16 | 13.10 | 14.10 | 7.88 | 3.32 | 0.86 | -3.62 | -0.66 | 0.64 | -0.37 | -0.08 | 0.90 | 0.98 | |
| % of Revenue | 14.65 | 14.82 | 14.47 | 13.75 | 13.93 | 13.87 | 14.24 | 15.41 | 16.06 | 17.04 | 17.33 | 17.30 | 17.21 | 16.43 | 16.39 | 16.47 | 16.00 | 15.36 | 14.98 | 14.66 |
| R&D | 89 | 105 | 113 | 127 | 146 | 152 | 162 | 171 | 219 | 282 | 320 | 381 | 402 | 448 | 465 | 474 | 484 | 469 | 498 | 512 |
| Change (%) | 18.44 | 7.73 | 11.64 | 15.35 | 3.85 | 6.95 | 5.33 | 28.31 | 28.69 | 13.17 | 19.19 | 5.46 | 11.62 | 3.74 | 1.90 | 2.08 | -3.00 | 6.10 | 2.82 | |
| % of Revenue | 1.89 | 2.05 | 2.00 | 2.04 | 2.13 | 2.04 | 2.01 | 1.94 | 2.30 | 2.75 | 2.93 | 3.38 | 3.52 | 3.89 | 4.05 | 4.12 | 4.10 | 3.82 | 3.92 | 3.90 |
| OpEx | 3,704 | 4,114 | 4,501 | 4,925 | 5,488 | 5,996 | 6,571 | 7,277 | 7,923 | 8,600 | 9,110 | 9,475 | 9,696 | 9,848 | 9,915 | 10,029 | 10,278 | 10,557 | 10,860 | 11,181 |
| Change (%) | 11.07 | 9.42 | 9.42 | 11.43 | 9.26 | 9.58 | 10.74 | 8.89 | 8.54 | 5.93 | 4.00 | 2.34 | 1.57 | 0.68 | 1.15 | 2.49 | 2.71 | 2.88 | 2.96 | |
| % of Revenue | 78.52 | 80.13 | 79.47 | 79.11 | 80.13 | 80.55 | 81.55 | 82.76 | 83.01 | 83.77 | 83.67 | 84.06 | 84.88 | 85.36 | 86.34 | 87.19 | 87.14 | 85.99 | 85.49 | 85.27 |
| Operating Income | 1,013 | 1,020 | 1,163 | 1,301 | 1,361 | 1,448 | 1,486 | 1,516 | 1,622 | 1,667 | 1,778 | 1,797 | 1,728 | 1,690 | 1,569 | 1,473 | 1,517 | 1,719 | 1,844 | 1,931 |
| Change (%) | 0.69 | 13.98 | 11.89 | 4.65 | 6.35 | 2.69 | 2.00 | 6.96 | 2.77 | 6.66 | 1.11 | -3.86 | -2.21 | -7.12 | -6.11 | 2.94 | 13.35 | 7.24 | 4.73 | |
| % of Revenue | 21.48 | 19.87 | 20.53 | 20.89 | 19.87 | 19.45 | 18.45 | 17.24 | 16.99 | 16.23 | 16.33 | 15.94 | 15.12 | 14.64 | 13.66 | 12.81 | 12.86 | 14.01 | 14.51 | 14.73 |
| Interest Expense | -38 | -24 | -21 | -26 | -55 | -83 | -117 | -149 | -159 | -167 | -175 | -175 | -177 | -182 | -206 | -231 | -245 | -244 | -217 | -251 |
| Change (%) | -36.56 | -11.52 | 24.39 | 109.70 | 50.89 | 40.55 | 27.21 | 6.92 | 5.36 | 4.33 | 0.31 | 0.98 | 3.03 | 13.04 | 12.36 | 5.75 | -0.41 | -10.95 | 15.86 | |
| % of Revenue | -0.80 | -0.46 | -0.37 | -0.42 | -0.80 | -1.12 | -1.45 | -1.69 | -1.66 | -1.63 | -1.60 | -1.55 | -1.55 | -1.58 | -1.79 | -2.01 | -2.07 | -1.99 | -1.71 | -1.92 |
| Net Income | 1,008 | 1,172 | 1,317 | 1,258 | 1,423 | 1,661 | 1,664 | 1,682 | 1,582 | 1,375 | 1,474 | 1,575 | 1,553 | 1,601 | 1,483 | 1,928 | 1,884 | 1,793 | 1,868 | 1,381 |
| Change (%) | 16.32 | 12.31 | -4.44 | 13.12 | 16.69 | 0.19 | 1.04 | -5.92 | -13.11 | 7.21 | 6.89 | -1.44 | 3.13 | -7.35 | 30.00 | -2.31 | -4.80 | 4.18 | -26.07 | |
| % of Revenue | 21.37 | 22.84 | 23.25 | 20.21 | 20.78 | 22.31 | 20.66 | 19.12 | 16.57 | 13.39 | 13.54 | 13.98 | 13.59 | 13.88 | 12.92 | 16.77 | 15.97 | 14.61 | 14.71 | 10.53 |
Source: Capital IQ
